Alert: investors in fate therapeutics, inc. with substantial losses have opportunity to lead class action lawsuit - fate

San diego, california--(newsfile corp. - february 10, 2023) - the law firm of robbins geller rudman & dowd llp announces that purchasers or acquirers of fate therapeutics, inc. (nasdaq: fate) securities between april 2, 2020 and january 5, 2023, both dates inclusive (the "class period") have until march 22, 2023 to seek appointment as lead plaintiff in the fate therapeutics class action lawsuit. captioned hadian v. fate therapeutics, inc., no. 23-cv-00111 (s.d. cal.
FATE Ratings Summary
FATE Quant Ranking